Roche Holding AG Share Price London S.E.
Stocks
0QOK
CH0012032048
Pharmaceuticals
OTC Markets Traded|
Market Closed -
London S.E.
08:50:00 20/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 323.90 CHF | 0.00% |
|
0.00% | -1.29% |
| 20/08 | Roche's U.S. Subsidiary Genentech to Invest $750 Million in Manufacturing Expansion | DJ |
| 20/08 | Cancer vaccines finally garner the spotlight | ![]() |
| Market Cap | 30TCr 37TCr 32TCr 27TCr 51TCr 35,53600Cr 52TCr 3,52000Cr 1,37200Cr 17,80900Cr 1,39400Cr 1,36400Cr 58,96100Cr | P/E 2026 * |
20.7x | P/E 2027 * | 18.4x |
|---|---|---|---|---|---|
| Enterprise Value | 31TCr 38TCr 33TCr 28TCr 53TCr 36,83800Cr 54TCr 3,64900Cr 1,42200Cr 18,46200Cr 1,44600Cr 1,41400Cr 61,12000Cr | EV / Sales 2026 * |
4.91x | EV / Sales 2027 * | 4.59x |
| Free-Float |
88.78% | Yield 2026 * |
2.69% | Yield 2027 * | 2.75% |
Last Transcript: Roche Holding AG
| Current month | +0.48% | ||
| 6 months | -12.57% | ||
| Current year | -1.29% |
| Current year | 311.6 | 377 | |
| 1 year | 249.6 | 377 | |
| 3 years | 212.3 | 377 | |
| 5 years | 212.3 | 404.1 | |
| 10 years | 202.23 | 404.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 15/03/2023 | |
Alan Hippe
DFI | Director of Finance/CFO | 59 | 06/06/2011 |
| Chief Operating Officer | - | 01/10/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
André Hoffmann
BRD | Director/Board Member | 68 | 01/01/1996 |
Severin Schwan
CHM | Chairman | 59 | 15/03/2023 |
| Director/Board Member | 73 | 03/03/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 37TCr | ||
| -2.81% | +2.93% | +76.40% | +127.73% | 1,10900Cr | ||
| -2.21% | +2.02% | +49.50% | +55.01% | 64TCr | ||
| -1.56% | +4.39% | +25.19% | +74.39% | 46TCr | ||
| +1.20% | +2.62% | +41.69% | +45.78% | 37TCr | ||
| -0.61% | +2.10% | +23.43% | +41.34% | 30TCr | ||
| +0.32% | +3.25% | +0.94% | +13.42% | 26TCr | ||
| -1.95% | +3.80% | +46.31% | +65.66% | 23TCr | ||
| -1.10% | -0.70% | -14.31% | -52.66% | 20TCr | ||
| -2.82% | +3.84% | +20.81% | +89.04% | 18TCr | ||
| Average | -1.15% | +3.00% | +30.00% | +51.08% | 41.79TCr | |
| Weighted average by Cap. | -1.48% | +3.26% | +43.26% | +70.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.26TCr 7.84TCr 6.71TCr 5.75TCr 11TCr 7,50300Cr 11TCr 74TCr 29TCr 3,76000Cr 29TCr 29TCr 12,44900Cr | 6.55TCr 8.2TCr 7.02TCr 6.01TCr 11TCr 7,84200Cr 12TCr 78TCr 30TCr 3,93000Cr 31TCr 30TCr 13,01100Cr |
| Net income | 1.45TCr 1.82TCr 1.55TCr 1.33TCr 2.5TCr 1,73800Cr 2.55TCr 17TCr 6.71TCr 87TCr 6.82TCr 6.67TCr 2,88300Cr | 1.63TCr 2.04TCr 1.75TCr 1.5TCr 2.82TCr 1,95600Cr 2.87TCr 19TCr 7.55TCr 98TCr 7.68TCr 7.51TCr 3,24600Cr |
| Net Debt | 1.09TCr 1.36TCr 1.16TCr 997.11Cr 1.87TCr 1,30200Cr 1.91TCr 13TCr 5.03TCr 65TCr 5.11TCr 5TCr 2,16000Cr | 401.96Cr 503.17Cr 430.81Cr 368.83Cr 693.06Cr 48TCr 706.7Cr 4.77TCr 1.86TCr 24TCr 1.89TCr 1.85TCr 80TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | CHF 323.90 | 0.00% | 582 |
| 19/26/19 | CHF 323.90 | 0.00% | 57,386 |
| 18/26/18 | CHF 323.90 | 0.00% | 3,22,267 |
| 17/26/17 | CHF 323.90 | 0.00% | 1,00,964 |
| 14/26/14 | CHF 323.90 | 0.00% | 70 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROP Stock
- 0QOK Stock
Select your edition
All financial news and data tailored to specific country editions



















